News Column

United States : MAXIM GROUP acquires additional units

September 4, 2014

ContraFect Corp. declared that Maxim Group L.L.C., the underwriter of its initial public offering, has exercised its over-allotment option in connection with the IPO.

ContraFect Corp is a biotechnology company based in Yonkers. Maxim Group is acquiring 880,333 extra units at the initial public offering price of $6 per unit, minus underwriting discounts and expenses.

The exercise helps ContraFect s IPO to total 6,880,333 units, with gross proceeds of $41,281,998, of which $5,281,998 was increased through Maxim s exercise of the over-allotment option. The underwriter s total over-allotment option was for 900,000 additional units.

Maxim acted as the sole book-running manager of the offering.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: TendersInfo (India)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters